Literature DB >> 18567577

Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins.

R John Solaro1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18567577      PMCID: PMC2556011          DOI: 10.1074/jbc.R800037200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  48 in total

Review 1.  At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function.

Authors:  W Glen Pyle; R John Solaro
Journal:  Circ Res       Date:  2004-02-20       Impact factor: 17.367

Review 2.  Calcium, thin filaments, and the integrative biology of cardiac contractility.

Authors:  Tomoyoshi Kobayashi; R John Solaro
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

3.  Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.

Authors:  M G Vila-Petroff; A Younes; J Egan; E G Lakatta; S J Sollott
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

Review 4.  Distinctive activation mechanisms and functions for protein kinase Cdelta.

Authors:  Susan F Steinberg
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

5.  Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants.

Authors:  T A Noland; R L Raynor; N M Jideama; X Guo; M G Kazanietz; P M Blumberg; R J Solaro; J F Kuo
Journal:  Biochemistry       Date:  1996-11-26       Impact factor: 3.162

6.  Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1.

Authors:  T A Noland; X Guo; R L Raynor; N M Jideama; V Averyhart-Fullard; R J Solaro; J F Kuo
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

7.  Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo.

Authors:  Brian B Roman; Paul H Goldspink; Elyse Spaite; Dalia Urboniene; Ron McKinney; David L Geenen; R John Solaro; Peter M Buttrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01-15       Impact factor: 4.733

8.  In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts.

Authors:  Y Takeishi; G Chu; D M Kirkpatrick; Z Li; H Wakasaki; E G Kranias; G L King; R A Walsh
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

9.  Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

Authors:  Rick B Vega; Brooke C Harrison; Eric Meadows; Charles R Roberts; Philip J Papst; Eric N Olson; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart.

Authors:  N Bowling; R A Walsh; G Song; T Estridge; G E Sandusky; R L Fouts; K Mintze; T Pickard; R Roden; M R Bristow; H N Sabbah; J L Mizrahi; G Gromo; G L King; C J Vlahos
Journal:  Circulation       Date:  1999-01-26       Impact factor: 29.690

View more
  69 in total

1.  Loss of enigma homolog protein results in dilated cardiomyopathy.

Authors:  Hongqiang Cheng; Kensuke Kimura; Angela K Peter; Li Cui; Kunfu Ouyang; Tao Shen; Yujie Liu; Yusu Gu; Nancy D Dalton; Sylvia M Evans; Kirk U Knowlton; Kirk L Peterson; Ju Chen
Journal:  Circ Res       Date:  2010-06-10       Impact factor: 17.367

2.  Why is it important to analyze the cardiac sarcomere subproteome?

Authors:  R John Solaro; Chad M Warren; Sarah B Scruggs
Journal:  Expert Rev Proteomics       Date:  2010-06       Impact factor: 3.940

3.  Cardiac myosin binding protein C and its phosphorylation regulate multiple steps in the cross-bridge cycle of muscle contraction.

Authors:  Arthur T Coulton; Julian E Stelzer
Journal:  Biochemistry       Date:  2012-04-06       Impact factor: 3.162

4.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

5.  Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment.

Authors:  Benjamin R Nixon; Shane D Walton; Bo Zhang; Elizabeth A Brundage; Sean C Little; Mark T Ziolo; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-03-19       Impact factor: 5.000

Review 6.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

7.  Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells.

Authors:  Chao Chen; Jia-Bao Liu; Zhi-Ping Bian; Jin-Dan Xu; Heng-Fang Wu; Chun-Rong Gu; Yi Shi; Ji-Nan Zhang; Xiang-Jian Chen; Di Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling.

Authors:  Sonya C Bardswell; Friederike Cuello; Alexandra J Rowland; Sakthivel Sadayappan; Jeffrey Robbins; Mathias Gautel; Jeffery W Walker; Jonathan C Kentish; Metin Avkiran
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

Review 9.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease.

Authors:  David Barefield; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

10.  Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.

Authors:  Camille L Birch; Samantha M Behunin; Marissa A Lopez-Pier; Christiane Danilo; Yulia Lipovka; Chandra Saripalli; Henk Granzier; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.